Copley Acquisition reports about $137M in redemptions
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Copley Acquisition Corp (COPL) reported third-quarter net income of $615,436, down from $1,731,604 in 2025; general and administrative expenses were $1,019,445, versus $72,530. Nine-month net income was $3,389,989, compared with $2,570,449 in 2025.
The company said conditions raise substantial doubt about its ability to continue as a going concern. At September 30, 2026, it had $110,602 cash and a $1,420,286 working capital deficit, and said continued operations depend on funding and completing a business combination within its deadline. The proposed combination with Ignite was mutually terminated on October 9, 2026.
On November 2, shareholders approved up to 12 one-month extensions through November 2, 2027, subject to required approvals, implementation and funding; each requires a $200,000 Trust Account deposit. The first deposit extended the deadline to December 2, 2026. Holders exercised redemption rights for 12,899,720 Class A shares, for approximately $137.1 million, leaving approximately $46.2 million in trust and 4,350,280 redeemable Class A shares outstanding.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointNine-month net income rose to $3,389,989 from $2,570,449.
Negative
- Major pointSubstantial doubt about the ability to continue as a going concern accompanies a $1,420,286 working capital deficit at September 30, 2026.
- Major pointNovember 2 redemptions totaled approximately $137.1 million, leaving approximately $46.2 million in the Trust Account. 58% of market cap
- Moderate pointThird-quarter net income fell to $615,436 from $1,731,604.
- Moderate pointThe proposed Ignite combination terminated on October 9, 2026.
Filing Explained
An
Key Figures
Key Terms
going concern financial
temporary equity financial
over-allotment option financial
redemption value financial
cashless basis financial
fair value hierarchy financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many COPL shares were redeemed on November 2, 2026?
What is COPL’s extended business-combination deadline?
Why did COPL report substantial doubt about going concern?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
(Mark One)
For the quarterly period ended
or
For the transition period from ____________ to ____________
Commission File Number:
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices, including zip code)
+
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| The | ||||
| The | ||||
| The |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| ☒ | Smaller reporting company | ||
| Emerging growth company | |||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☒
As of November 19, 2026, the registrant had a total of
COPLEY ACQUISITION CORP
INDEX TO FORM 10-Q
| PAGE | ||
| PART I - FINANCIAL INFORMATION | 1 | |
| Item 1. Financial Statements | 1 | |
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 25 | |
| Item 3. Quantitative and Qualitative Disclosures About Market Risk | 31 | |
| Item 4. Controls and Procedures | 31 | |
| PART II - OTHER INFORMATION | 32 | |
| Item 1. Legal Proceedings | 32 | |
| Item 1A. Risk Factors | 32 | |
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 32 | |
| Item 3. Defaults Upon Senior Securities | 32 | |
| Item 4. Mine Safety Disclosure | 32 | |
| Item 5. Other Information | 32 | |
| Item 6. Exhibits | 33 | |
| Signatures | 34 |
i
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
Certain statements in this Quarterly Report on Form 10-Q are “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical facts, including statements regarding our future results of operations and financial position, our business strategy and plans and our objectives for future operations, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with the SEC on March 31, 2026, our Prospectus dated April 30, 2025, Part II, Item 1A of this Quarterly Report on Form 10-Q and in any subsequent filing we make with the SEC, as well as in any documents incorporated by reference that describe risks and factors that could cause results to differ materially from those projected in these forward-looking statements.
Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this Quarterly Report on Form 10-Q may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.
Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, achievements or events and circumstances reflected in the forward-looking statements will occur. We are under no duty to update any of these forward-looking statements after completion of this Quarterly Report on Form 10-Q to conform these statements to actual results or revised expectations.
ii
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.
COPLEY ACQUISITION CORP
INDEX TO FINANCIAL STATEMENTS
| Page | ||
|---|---|---|
| Condensed Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025 | 2 | |
| Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited) | 3 | |
| Condensed Statements of Changes in Shareholders’ Deficit for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited) | 4 | |
| Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025 (Unaudited) | 6 | |
| Notes to Condensed Financial Statements (Unaudited) | 7 |
1
COPLEY ACQUISITION CORP
CONDENSED BALANCE SHEETS
| September 30, 2026 |
December 31, 2025 |
|||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | $ | $ | ||||||
| Prepaid expenses - current | ||||||||
| Total current assets | ||||||||
| Investments held in Trust Account | ||||||||
| Prepaid expenses - non-current | - | |||||||
| Total Assets | $ | $ | ||||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT | ||||||||
| Current Liabilities | ||||||||
| Accrued expenses | $ | $ | ||||||
| Working capital loan - related party | ||||||||
| Total current liabilities | ||||||||
| Deferred underwriting fees | ||||||||
| Total Liabilities | ||||||||
| Commitments and Contingencies (Note 6) | ||||||||
| Class A ordinary shares, $ |
||||||||
| Shareholders’ Deficit | ||||||||
| Preferred shares, $ |
- | - | ||||||
| Class A ordinary shares, $ |
||||||||
| Class B ordinary shares, $ |
||||||||
| Additional paid-in capital | - | - | ||||||
| Accumulated deficit | ( |
) | ( |
) | ||||
| Total Shareholders’ Deficit | ( |
) | ( |
) | ||||
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited condensed financial statements.
2
COPLEY ACQUISITION CORP
CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)
| For the Three Months Ended September 30, |
For the Nine Months Ended September 30, |
|||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| General and administrative expenses | $ | $ | $ | $ | ||||||||||||
| Loss from operations | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Other income | ||||||||||||||||
| Interest earned on investments held in Trust Account | ||||||||||||||||
| Interest from the bank account | ||||||||||||||||
| Net income | $ | $ | $ | $ | ||||||||||||
| Basic and diluted weighted average ordinary shares outstanding, redeemable ordinary shares | ||||||||||||||||
| Basic and diluted net income per share, redeemable ordinary shares | $ | $ | $ | $ | ||||||||||||
| Basic and diluted weighted average ordinary shares outstanding, non-redeemable ordinary shares | ||||||||||||||||
| Basic and diluted net income per share, non-redeemable ordinary shares | $ | $ | $ | $ | ||||||||||||
The accompanying notes are an integral part of these unaudited condensed financial statements.
3
COPLEY ACQUISITION CORP
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026
(Unaudited)
| Ordinary Shares | Additional | Total | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Class A | Class B | Paid-in | Accumulated | Shareholders’ | ||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Deficit | ||||||||||||||||||||||
| Balance - January 1, 2026 | $ | $ | $ | - | $ | ( |
) | $ | ( |
) | ||||||||||||||||||
| Subsequent measurement of ordinary shares subject to possible redemption | - | - | - | - | - | ( |
) | ( |
) | |||||||||||||||||||
| Net income | - | - | - | - | - | |||||||||||||||||||||||
| Balance - March 31, 2026 (Unaudited) | $ | $ | $ | - | $ | ( |
) | $ | ( |
) | ||||||||||||||||||
| Subsequent measurement of ordinary shares subject to possible redemption | - | - | - | - | - | ( |
) | ( |
) | |||||||||||||||||||
| Net income | - | - | - | - | - | |||||||||||||||||||||||
| Balance - June 30, 2026 (Unaudited) | $ | $ | $ | - | $ | ( |
) | $ | ( |
) | ||||||||||||||||||
| Subsequent measurement of ordinary shares subject to possible redemption | - | - | - | - | - | ( |
) | ( |
) | |||||||||||||||||||
| Net income | - | - | - | - | - | |||||||||||||||||||||||
| Balance - September 30, 2026 (Unaudited) | $ | $ | $ | - | $ | ( |
) | $ | ( |
) | ||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed financial statements.
4
COPLEY ACQUISITION CORP
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT - (Continued)
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025
(Unaudited)
| Ordinary Shares | Additional | Total | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Class A | Class B(1) | Paid-in | Accumulated | Shareholders’ | ||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Deficit | ||||||||||||||||||||||
| Balance - January 1, 2025 | - | $ | - | $ | $ | $ | ( |
) | $ | ( |
) | |||||||||||||||||
| Net loss | - | - | - | - | - | ( |
) | ( |
) | |||||||||||||||||||
| Balance - March 31, 2025 (Unaudited) | - | $ | - | $ | $ | $ | ( |
) | $ | ( |
) | |||||||||||||||||
| Sale of private placement units | - | - | - | |||||||||||||||||||||||||
| Issuance of representative shares | - | - | - | |||||||||||||||||||||||||
| Fair value of warrants included in public units | - | - | - | - | - | |||||||||||||||||||||||
| Allocated value of offering costs to public warrants and private placement units | - | - | - | - | ( |
) | - | ( |
) | |||||||||||||||||||
| Remeasurement of ordinary shares subject to possible redemption | - | - | - | - | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
| Subsequent measurement of ordinary shares subject to possible redemption | - | - | - | - | - | ( |
) | ( |
) | |||||||||||||||||||
| Net income | - | - | - | - | - | |||||||||||||||||||||||
| Balance - June 30, 2025 (Unaudited) | $ | $ | $ | - | $ | ( |
) | $ | ( |
) | ||||||||||||||||||
| Subsequent measurement of ordinary shares subject to possible redemption | - | - | - | - | - | ( |
) | ( |
) | |||||||||||||||||||
| Net income | - | - | - | - | - | |||||||||||||||||||||||
| Balance - September 30, 2025 (Unaudited) | $ | $ | $ | - | $ | ( |
) | $ | ( |
) | ||||||||||||||||||
| (1) |
|
The accompanying notes are an integral part of these unaudited condensed financial statements.
5
COPLEY ACQUISITION CORP
CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)
| For the Nine Months Ended September 30, |
||||||||
| 2026 | 2025 | |||||||
| Cash Flows from Operating Activities | ||||||||
| Net income | $ | $ | ||||||
| Adjustments to reconcile net income to net cash used in operating activities: | ||||||||
| Interest earned on investments held in Trust Account | ( |
) | ( |
) | ||||
| Changes in operating assets and liabilities: | ||||||||
| Prepaid expenses | ( |
) | ||||||
| Accrued expenses | ||||||||
| Net cash used in operating activities | ( |
) | ( |
) | ||||
| Cash Flows from Investing Activities | ||||||||
| Cash deposited in Trust Account | - | ( |
) | |||||
| Net cash used in investing activities | - | ( |
) | |||||
| Cash Flows from Financing Activities | ||||||||
| Proceeds received from initial public offering, gross | - | |||||||
| Proceeds received from issuance of private placement units | - | |||||||
| Offering costs paid | - | ( |
) | |||||
| Proceeds from draw on working capital loan - related party | - | |||||||
| Repayment of promissory note - related party | - | ( |
) | |||||
| Net cash provided by financing activities | ||||||||
| Net change in cash | ||||||||
| Cash - Beginning of period | - | |||||||
| Cash - End of period | $ | $ | ||||||
| Supplemental disclosure of noncash investing and financing activities: | ||||||||
| Deferred offering costs paid by related party | $ | - | $ | |||||
| Accrued expenses paid by related party | $ | - | $ | |||||
| Reclassification of due to related party into promissory note - related party | $ | - | $ | |||||
| Reclassification of promissory note - related party into working capital loan - related party | $ | - | $ | |||||
| Fair value of representative shares | $ | - | $ | |||||
| Offering costs charged to additional paid-in capital | $ | - | $ | |||||
| Proceeds allocated to warrants | $ | - | $ | |||||
| Allocation of offering costs to ordinary shares subject to redemption | $ | - | $ | |||||
| Remeasurement adjustment on ordinary shares subject to possible redemption | $ | - | $ | |||||
| Deferred underwriting commissions | $ | - | $ | |||||
| Reclassification of value for Class A ordinary shares | $ | - | $ | |||||
The accompanying notes are an integral part of these unaudited condensed financial statements.
6
COPLEY ACQUISITION CORP
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2026
(Unaudited)
NOTE 1. ORGANIZATION AND BUSINESS OPERATIONS
Copley Acquisition Corp (the “Company”) is an exempted company with limited liability incorporated under the laws of the Cayman Islands on November 26, 2024. The Company was formed for the purpose of effectuating a merger, shares exchange, asset acquisition, shares purchase, reorganization, or other similar business combination with one or more target businesses, which is referred to individually as a “target business” (the “Business Combination”).
The Company’s efforts to identify a prospective target business are not limited to a particular industry or geographic location but are initially focused in the Asia Pacific and North American regions. The Company executive officers and directors are located in Hong Kong, with significant ties to Hong Kong and, to a lesser degree, the People’s Republic of China. Hong Kong, Taiwan and Macau are collectively referred to herein as the “PRC”. Further, due to the fact that most of the Company’s executive officers and directors are located in or have significant ties to the PRC, it may make the Company a less attractive partner to certain potential target businesses, outside the PRC, than a non-PRC related Special Purpose Acquisition Company (“SPAC”). However, the Company will not undertake its initial Business Combination with any company being based in or having a majority of its operations in the PRC. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of September 30, 2026, the Company had not yet commenced any operations. All activity for the period from November 26, 2024 (inception) through September 30, 2026 relates to the Company’s formation, the initial public offering (the “Initial Public Offering”), which is described below, and its search for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering, which will be held in the Trust Account for potential redemption of the Public Shares (as described below). The Company has selected December 31 as its fiscal year end.
The Company’s founder and sponsor is Copley Acquisition Sponsors, LLC (the “Sponsor”).
Financing
The registration statement for the Company’s Initial Public Offering was declared effective on April 30, 2025. On May 2, 2025, the Company consummated the Initial Public Offering of
Simultaneously with the consummation of the Initial Public Offering and the sale of the Units, the Company consummated the private placement (“Private Placement”) of
Transaction costs amounted to $
7
Upon the closing of the Initial Public Offering and the Private Placement, $
New York Stock Exchange rules require that the Company must complete one or more Business Combinations having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of signing a definitive agreement in connection with the initial Business Combination. The board of directors will make the determination as to the fair market value of the initial Business Combination. If the board of directors is not able to independently determine the fair market value of the initial Business Combination, the Company will obtain an opinion from an independent entity that commonly renders valuation opinions. While the Company considers it unlikely that the board of directors will not be able to make an independent determination of the fair market value of the initial Business Combination, it may be unable to do so if it is less familiar or experienced with the business of a particular target or if there is a significant amount of uncertainty as to the value of a target’s assets or prospects.
The Company will provide holders of its Public Shares with the opportunity to redeem all or a portion of their Public Shares upon the completion of the Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination (regardless of whether they vote for or against the proposed Business Combination or do not vote at all) or (ii) by means of a tender offer.
All of the Class A ordinary shares sold as part of the units in the Company’s Initial Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with liquidation, if there is a shareholder vote or tender offer in connection with initial business combination, and in connection with certain amendments to the Company’s amended and restated memorandum and articles of association (as may be amended and restated from time to time). In accordance with U.S. Securities and Exchange Commission (“SEC”) guidance on redeemable equity instruments, redemption provisions not solely within the control of a company require ordinary shares subject to redemption to be classified outside of permanent equity. Accordingly, all of the Public Shares are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. Given that the Class A ordinary shares sold as part of the units in the offering were issued with other freestanding instruments, the initial carrying value of Class A ordinary shares classified as temporary equity were the allocated proceeds determined in accordance with ASC 470-20 (defined below). The accretion or remeasurement is recognized as a reduction to additional paid-in capital to the extent available, with any remaining amount charged to accumulated deficit. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
Each public shareholder may elect to redeem their Public Shares without voting and, if they do vote, irrespective of whether they vote for or against the proposed transaction. In addition, initial shareholders, directors and officers have entered into a letter agreement, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and Public Shares held by them in connection with the completion of a Business Combination.
8
The Company has determined not to have a minimum net tangible asset requirement to consummate any Business Combination which could be subject to Rule 419 promulgated under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, if the Company seeks to consummate an initial Business Combination with a target business that imposes any type of working capital closing condition or requires the Company to have a minimum amount of funds available from the Trust Account upon consummation of such initial Business Combination, such minimum funding condition may limit the Company’s ability to consummate such initial Business Combination (as the Company may be required to have a lesser number of shares redeemed) and may force the Company to seek third party financing which may not be available on terms acceptable to the Company or at all. As a result, the Company may not be able to consummate such an initial Business Combination and the Company may not be able to locate another suitable target within the applicable time period, if at all.
Business Combination
Under its amended and
restated memorandum and articles of association in effect at September 30, 2026, the Company had until November 2, 2026, 18 months
from the closing of the Initial Public Offering, to complete an initial Business Combination, subject to two additional three-month
extensions for a total completion time of up to 24 months (the “Completion Window”). On November 2, 2026, the
Company’s shareholders approved an amendment to the Company’s amended and restated memorandum and articles of
association to permit up to twelve one-month extensions of the deadline to complete an initial Business Combination from November 2,
2026 to as late as November 2, 2027, subject to the required approvals, implementation and extension funding (see Note 10). However,
if the Company is unable to complete its initial Business Combination within the Completion Window, the Company will (i) cease all
operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days
thereafter (and subject to lawfully available funds therefor), redeem the Public Shares, at a per-share price, payable in cash,
equal to the aggregate amount then on deposit in the Trust Account, including interest (less taxes payable and up to $
On June 10, 2026, the Company entered into a Business Combination Agreement with Ignite Proteomics Holdings, Inc., Ignite Proteomics, LLC (“Ignite”) and related parties, which was subsequently terminated (see below).
Completion of the proposed transaction was subject to customary and negotiated closing conditions, including shareholder and equityholder approvals, effectiveness of the registration statement, required regulatory and stock exchange approvals, satisfaction or waiver of minimum cash conditions, and compliance with the representations, warranties and covenants in the Business Combination Agreement.
The Business Combination Agreement provided for a September 30, 2026 outside date, subject to an automatic 30-day extension and further extensions in accordance with the agreement, and included other customary termination rights.
The proposed Business Combination was not completed at September 30, 2026. No assets, liabilities or results of operations of Ignite have been included in these unaudited condensed financial statements as a result of the proposed transaction.
On October 9, 2026, the parties mutually terminated the Business Combination Agreement, effective immediately. Each party is responsible for its own transaction and termination expenses, subject to the terms of the Termination Agreement. The Company intends to continue pursuing an initial Business Combination (see Note 10 for the termination terms and related subsequent events).
9
Going Concern Consideration
As of September 30, 2026, the Company had cash of $
In addition, the Company’s officers, directors and Sponsor may, but are not obligated to, provide additional Working Capital Loans to fund operating activities and transaction costs pending completion of an initial Business Combination. As of September 30, 2026, the outstanding balance under the Working Capital Loan was $
On October 9, 2026, the Business Combination Agreement with Ignite was mutually terminated. Accordingly, the financing contemplated for that proposed transaction is not a source of funding for the Company’s current liquidity plans. On October 6, 2026, the Company increased the maximum principal amount available under its Sponsor note to $
If the Company is unable to obtain sufficient financing or complete an initial Business Combination within the applicable Completion Window, it may be required to curtail operations and liquidate in accordance with its amended and restated memorandum and articles of association. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date these unaudited condensed financial statements are issued. The accompanying unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s latest audited financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC on March 31, 2026. The interim results for the three and nine months ended September 30, 2026, are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.
10
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with those of another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Warrant Instruments
The Company has accounted for the Public Warrants issued in connection with the Initial Public Offering and the Private Placement Warrants issued in the Private Placement in accordance with the guidance contained in ASC Topic 815, “Derivatives and Hedging.” Accordingly, the Company evaluated and has classified the warrant instruments under equity treatment at their assigned values. As of September 30, 2026 and December 31, 2025, there were
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of September 30, 2026 and December 31, 2025, the Company had cash of $
11
Investments Held in Trust Account
The Company’s portfolio of investments held in the Trust Account is comprised of investments only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on investments held in Trust Account in the accompanying condensed statements of operations. The estimated fair value of investments held in the Trust Account is determined using available market information. As of September 30, 2026 and December 31, 2025, the Trust Account had a balance of $
Offering Costs Associated with the Initial Public Offering
The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Offering costs consist of legal, accounting, and other costs (including underwriting discounts and commissions) incurred that are directly related to the Initial Public Offering. ASC 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components.
The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the warrants and then to the Class A ordinary shares. Offering costs allocated to the Public Shares were charged to temporary equity, and offering costs allocated to the Public Warrants and the Private Placement Units were charged to shareholders’ deficit as the Public Warrants and the Private Placement Warrants, after management’s evaluation, are accounted for under equity treatment.
Net Income per Ordinary Share
The Company complies with accounting and disclosure requirements of ASC 260, “Earnings Per Share.” The condensed statements of operations include a presentation of income per redeemable share and income per non-redeemable share following the two-class method of income per share. In order to determine the net income attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income allocable to both the redeemable shares and non-redeemable shares and the undistributed income is calculated using the total net income less any dividends paid. The Company then allocated the undistributed income ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. The calculation of diluted net income per share does not consider the effect of the Public Warrants or Private Placement Warrants since the exercise of the warrants is contingent upon the occurrence of a future event. As of September 30, 2026 and December 31, 2025, the Company did
12
The net income per share presented in the condensed statements of operations is based on the following:
| Schedule of basic and diluted net loss per share | ||||||||||||||||
| For the Three Months Ended September 30, | ||||||||||||||||
| 2026 | 2025 | |||||||||||||||
| Redeemable Shares |
Non-Redeemable Shares |
Redeemable Shares |
Non-Redeemable Shares |
|||||||||||||
| Particulars | ||||||||||||||||
| Basic and diluted net income per share: | ||||||||||||||||
| Weighted average shares outstanding | ||||||||||||||||
| Ownership percentage | % | % | % | % | ||||||||||||
| Numerators: | ||||||||||||||||
| Allocation of net income | $ | $ | $ | $ | ||||||||||||
| Denominators: | ||||||||||||||||
| Weighted average shares outstanding | ||||||||||||||||
| Basic and diluted net income per share | $ | $ | $ | $ | ||||||||||||
| For the Nine Months Ended September 30, | ||||||||||||||||
| 2026 | 2025 | |||||||||||||||
| Redeemable Shares |
Non-Redeemable Shares |
Redeemable Shares |
Non-Redeemable Shares |
|||||||||||||
| Particulars | ||||||||||||||||
| Basic and diluted net income per share: | ||||||||||||||||
| Weighted average shares outstanding | ||||||||||||||||
| Ownership percentage | % | % | % | % | ||||||||||||
| Numerators: | ||||||||||||||||
| Allocation of net income | $ | $ | $ | $ | ||||||||||||
| Denominators: | ||||||||||||||||
| Weighted average shares outstanding | ||||||||||||||||
| Basic and diluted net income per share | $ | $ | $ | $ | ||||||||||||
Fair Value Measurements
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.
The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.
13
| ● | Level 1 - Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. |
| ● | Level 2 - Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. |
| ● | Level 3 - Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. |
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $
Income Taxes
The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that is included in the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2026 or December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position.
There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements.
Class A Ordinary Shares Subject to Possible Redemption
The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit.
14
Accordingly, as of September 30, 2026 and December 31, 2025, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets, as reconciled in the following table:
| Schedule of Class A ordinary shares subject to possible redemption | ||||
| Gross proceeds | $ | |||
| Less: Proceeds allocated to public warrants | ( |
) | ||
| Less: Public Shares issuance costs | ( |
) | ||
| Plus: Remeasurement of carrying value to redemption value | ||||
| Class A ordinary shares subject to possible redemption, May 2, 2025 | ||||
| Plus: Subsequent measurement of ordinary shares subject to possible redemption | ||||
| Class A ordinary shares subject to possible redemption, December 31, 2025 | ||||
| Plus: Subsequent measurement of ordinary shares subject to possible redemption | ||||
| Class A ordinary shares subject to possible redemption, March 31, 2026 | ||||
| Plus: Subsequent measurement of ordinary shares subject to possible redemption | ||||
| Class A ordinary shares subject to possible redemption, June 30, 2026 | ||||
| Plus: Subsequent measurement of ordinary shares subject to possible redemption | ||||
| Class A ordinary shares subject to possible redemption, September 30, 2026 | $ |
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the condensed statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the condensed balance sheets as current or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
Recent Accounting Standards
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.
NOTE 3. INITIAL PUBLIC OFFERING
Pursuant to the Initial Public Offering, the Company sold
15
NOTE 4. PRIVATE PLACEMENT
Simultaneously with the consummation of the Initial Public Offering and the sale of the Units, the Company consummated the private placement (“Private Placement”) of
Each Private Placement Unit is identical to the Units sold in the Initial Public Offering, except that it is not redeemable, transferable, assignable or salable by the Sponsor until 30 days after the completion of its initial Business Combination, except (a) in each case, to any members of the Sponsor, officers or directors of the Company or the Sponsor or the Sponsor’s members, any affiliates or family members of any of officers or directors of the Company or the Sponsor or the Sponsor’s members, any members or partners of the Sponsor or the Sponsor’s members or any affiliates of the Sponsor or the Sponsor’s members or the Sponsor’s partner including any employees of such affiliates; (b) in the case of an individual, by gift to a member of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family or an affiliate of such person, or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) in the case of a trust, by distribution to one or more permissible beneficiaries of such trust; (f) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement, in connection with an extension of the Completion Window or in connection with the consummation of a Business Combination at prices no greater than the price at which the securities were originally purchased; (g) to the Company for no value for cancellation in connection with the consummation of the initial Business Combination; (h) in the event of the Company’s liquidation prior to the completion of its initial Business Combination; (i) by virtue of the laws of the State of Delaware, the Sponsor’s limited liability company agreement, upon dissolution of the Sponsor; or (j) in the event that, subsequent to the consummation of an initial Business Combination, the Company completes a liquidation, merger, share exchange or other similar transaction which results in all of shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement.
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On December 3, 2024, the Sponsor purchased
The Founder Shares are identical to the Class A ordinary shares included in the Units sold in the Initial Public Offering, except that:
| ● | the Founder Shares are subject to certain transfer restrictions; |
| ● | the Founder Shares holders have the exclusive right to vote, prior to the initial Business Combination, on the appointment or removal of the members of the board of directors; and |
| ● | the Founder Shares are entitled to registration rights. |
16
The initial shareholders, Sponsor, officers and directors have entered into a letter agreement, pursuant to which they have agreed to (i) waive their redemption rights with respect to any Founder Shares and public shares they hold in connection with the completion of an initial Business Combination, (ii) waive their redemption rights with respect to any Founder Shares and public shares they hold in connection with a shareholder vote to approve an amendment to the amended and restated memorandum and articles of association to modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if the Company has not consummated an initial Business Combination within the Completion Window or with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity, and (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to complete an initial Business Combination within the Completion Window.
The Founder Shares will automatically convert into Class A ordinary shares in connection with the consummation of the initial Business Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in this offering and related to or in connection with the closing of the initial Business Combination, the ratio at which Class B ordinary shares convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, 25% of the sum of (i) the Founder Shares and public shares issued and outstanding upon the completion of this offering (including any public shares issued pursuant to the exercise of the underwriters’ over-allotment option), plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon the conversion or exercise of any equity-linked securities issued or deemed issued, in connection with the closing of the Initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent units issued to the Sponsor or any of its affiliates or to officers or directors upon conversion of working capital loans and extension loans made) minus (iii) any Class A ordinary shares redeemed by public shareholders in connection with an initial Business Combination and any Class A ordinary shares redeemed by public shareholders in connection with any amendment to the Company’s amended and restated memorandum and articles of association made prior to the consummation of an initial Business Combination (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with an initial Business Combination or to redeem 100% of the Company’s public shares if it does not complete an initial Business Combination within the Completion Window or (B) with respect to any other material provisions relating to the rights of holders of Class A ordinary shares or pre-Business Combination activity; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis. The foregoing is subject to adjustment (unless otherwise provided in the definitive agreement for the initial Business Combination) for share subdivisions, share dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided in the prospectus.
With certain limited exceptions, the Founder Shares are not transferable, assignable or saleable (except to officers and directors and other persons or entities affiliated with the Sponsor, each of whom will be subject to the same transfer restrictions) until the earlier of (i) 180 days after the completion of the initial Business Combination; or (ii) subsequent to the initial Business Combination (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 90 days after the initial Business Combination or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property.
17
Due to Related Party
The Sponsor paid certain formation, operating or deferred offering costs on behalf of the Company. These amounts are due on demand and non-interest bearing. During the period from November 26, 2024 (inception) through May 2, 2025, the Sponsor paid $
Promissory Note - Related Party
On December 3, 2024, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $
On May 2, 2025, the $
Working Capital Loans
In order to fund working capital deficiencies or finance transaction costs in connection with initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain officers and directors may, but are not obligated to, loan the Company funds as may be required, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion (“Working Capital Loans”). In addition, the Sponsor or an affiliate of the Sponsor or certain officers and directors may loan the Company funds of up to $
On June 12, 2025, the Company entered into a Working Capital Loan with the Sponsor, pursuant to which the Company was permitted to borrow up to $
18
NOTE 6. COMMITMENTS AND CONTINGENCIES
Registration Rights
The holders of the Founder Shares, Private Placement Units and units that may be issued upon conversion of loans made by the Sponsor or an affiliate of the Sponsor or certain officers and directors, and their permitted transferees, will have registration rights to require to register a sale of any of securities held by them (in the case of the Founder Shares, only after conversion to Class A ordinary shares) pursuant to a registration rights agreement that was signed prior to the effective date of the Initial Public Offering. These holders will be entitled to make up to three demands, excluding short form registration demands, to register such securities for sale under the Securities Act. In addition, these holders will have “piggyback” registration rights to include such securities in other registration statements filed by the Company and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
On May 2, 2025, the underwriters exercised their over-allotment option in full to purchase
The underwriters were entitled to a cash underwriting discount of $0.15 per Unit, or $
Additionally, the Company issued
NOTE 7. SHAREHOLDERS’ DEFICIT
Preferred Shares - The Company is authorized to issue
Class A Ordinary Shares - The Company is authorized to issue
Class B Ordinary Shares - The Company is authorized to issue
19
Prior to the initial Business Combination, only holders of the Class B ordinary shares will have the right to vote on the election of directors. Holders of the Class A ordinary shares will not be entitled to vote on the election of directors during such time. These provisions of the Company’s amended and restated memorandum and articles of association with class rights may not be amended without a special resolution under Cayman Islands law and the amended and restated articles of association, being a resolution passed by a majority of at least two-thirds (2/3) (or such higher approval threshold as specified in the Company’s amended and restated memorandum and articles of association) of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting of the Company of which notice specifying the intention to propose the resolution as a special resolution has been duly given, or a resolution approved in writing by all of the holders of the issued shares entitled to vote on such matter. With respect to any other matter submitted to a vote of its shareholders, including any vote in connection with the initial Business Combination, except as required by law, holders of the Founder Shares and holders of the Class A ordinary shares will vote together as a single class, with each share entitling the holder to one vote.
The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment pursuant to the Company’s amended and restated memorandum and articles of association.
Warrants
As of September 30, 2026 and December 31, 2025, there were
“Warrants”, which consist of Public Warrants, Private Placement Warrants, Working Capital Warrants and Extension Warrants, may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Warrants. The Warrants will become exercisable 30 days after the consummation of a Business Combination and will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation.
No Warrant shall be exercisable and the Company shall not be obligated to issue Class A ordinary shares upon exercise of a Warrant unless the Class A ordinary shares issuable upon such Warrant exercise have been registered, qualified or deemed to be exempt from registration or qualification under the securities laws of the state of residence of the Registered Holder of the Warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Warrant, the holder of such Warrant shall not be entitled to exercise such Warrant. In no event will the Company be required to net cash settle the Warrant exercise.
The Company agrees that as soon as practicable, but in no event later than thirty (30) Business Days after the closing of its initial Business Combination, it shall use its commercially reasonable efforts to file with the Commission a post-effective amendment to the Registration Statement, or a new registration statement registering, under the Securities Act, the issuance of the Class A ordinary shares issuable upon exercise of the Warrants. The Company shall use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such post-effective amendment or registration statement, and a current prospectus relating thereto, until the expiration of the Warrants in accordance with the provisions of this Agreement. If any such post-effective or registration statement has not been declared effective by the ninetieth (90th) Business Day following the closing of the initial Business Combination, holders of the Warrants shall have the right, during the period beginning on the ninety-first (91st) Business Day after the closing of the initial Business Combination and ending upon such post-effective amendment or registration statement being declared effective by the Commission, and during any other period when the Company shall fail to have maintained an effective registration statement covering the Class A ordinary shares issuable upon exercise of the Warrants, to exercise such Warrants on a “cashless basis,” by exchanging the Warrants (in accordance with Section 3(a)(9) of the Securities Act), and (i) in the event the Company so elects, the Company shall not be required to file or maintain in effect a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Warrants, notwithstanding anything in this Agreement to the contrary or (ii) if the Company does not so file or maintain such registration statement, the Company agrees to use its commercially reasonable efforts to register or qualify for sale the Class A ordinary shares issuable upon exercise of the Public Warrants under the blue sky laws of the state of residence of the exercising Warrant holder to the extent an exemption is not available.
20
Once the Warrants become exercisable, the Company may redeem the Warrants:
| ● | in whole and not in part; |
| ● | at a price of $ |
| ● | upon not less than 30 days’ prior written notice of redemption given after the warrants become exercisable to each warrant holder; and |
| ● | if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing at least 90 days after the completion of the initial Business Combination and ending on the third trading day prior to the date on which notice of the redemption is given. |
If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of Class A ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuance of Class A ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash to settle the warrants. If the Company is unable to complete a Business Combination within the Completion Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
The Private Placement Warrants, Working Capital Warrants and Extension Warrants are identical to the Public Warrants.
The Company assessed the Public Warrants, Private Placement Warrants, Working Capital Warrants and Extension Warrants to determine whether they should be classified as equity or liability instruments. This assessment was based on an evaluation of the specific terms of each instrument and applicable authoritative guidance in ASC 480, “Distinguishing Liabilities from Equity” (“ASC 480”), and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the instrument is a freestanding financial instrument pursuant to ASC 480 and meets the definition of a liability pursuant to ASC 480, and whether the instrument meets all of the requirements for equity classification under ASC 815, including whether the instrument is indexed to the Company’s own common stock, among other conditions for equity classification. Pursuant to such evaluation, the Public Warrants, Private Placement Warrants, Working Capital Warrants and Extension Warrants will be classified in shareholders’ deficit.
21
NOTE 8. FAIR VALUE MEASUREMENTS
The fair value of the Public Warrants issued in the Initial Public Offering was $
The following table presents the quantitative information regarding market assumptions used in the Level 3 valuation of the Public Warrants issued in the Initial Public Offering as of May 2, 2025:
| Schedule of Public Warrants issued in the Initial Public Offering | ||||
| Traded price of Unit | $ | |||
| Expected term to de-SPAC (years) | ||||
| Probability of de-SPAC | % | |||
| Risk-free rate | % | |||
| Industry volatility | % |
The fair value of the Representative Shares issued at the closing of the Initial Public Offering was $
| Schedule of Shares issued at the closing of the Initial Public Offering | ||||
| Traded price of Class A ordinary share | $ | |||
| Expected term to de-SPAC (years) | ||||
| Probability of de-SPAC | % | |||
| Risk-free rate | % | |||
| Restriction period post de-SPAC (years) | ||||
| Industry volatility | % | |||
| Discount for lack of marketability | % |
The following tables present information about the Company’s assets that are measured at fair value as of September 30, 2026 and December 31, 2025, and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
| Schedule of fair value hierarchy of the valuation inputs | ||||||||||||||||
| As of September 30, 2026 |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
|||||||||||||
| Assets: | ||||||||||||||||
| Investments held in Trust Account | $ | $ | $ | - | $ | - | ||||||||||
| As of December 31, 2025 |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
|||||||||||||
| Assets: | ||||||||||||||||
| Investments held in Trust Account | $ | $ | $ | - | $ | - | ||||||||||
22
NOTE 9. SEGMENT INFORMATION
ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker (“CODM”), or group, in deciding how to allocate resources and assess performance.
The Company’s CODM has been identified as the Chief Financial Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating and reportable segment.
The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the condensed statements of operations as net income or loss. The measure of segment assets is reported on the condensed balance sheets as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews general and administrative expenses, interest from the bank account, and interest earned on investments held in Trust Account, which are included in the accompanying condensed statements of operations, as well as the Trust Account and cash balances themselves.
The CODM reviews interest earned on investments held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement. General and administrative expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination within the Completion Window. The CODM also reviews general and administrative expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and the budget. General and administrative expenses, as reported on the condensed statements of operations, are the significant segment expenses provided to the CODM on a regular basis. All other segment items included in net income or loss are reported on the condensed statements of operations and described within their respective disclosures.
NOTE 10. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions occurring after September 30, 2026 through the date these unaudited condensed financial statements were issued. The following subsequent events were identified.
Working Capital Loan
On October 6, 2026, the Company issued an amended and restated convertible promissory note to the Sponsor, increasing the maximum aggregate principal amount available under the Working Capital Loan from $
Termination of Proposed Business Combination
On October 9, 2026, the Company and the other parties to the Business Combination Agreement entered into a mutual Termination Agreement, effective immediately. The Business Combination Agreement and related ancillary documents, including the Seller Support Agreements, the Insider Letter Amendment and the Lock-Up Agreements, were terminated, subject to specified surviving provisions. The Termination Agreement includes mutual releases of claims relating to the proposed transaction, other than claims under the Termination Agreement. Each party is responsible for the fees, costs and expenses it incurred in connection with the proposed transaction and its termination. The Company intends to continue pursuing an initial Business Combination.
23
Extension of Business Combination Deadline
On November 2, 2026, the
Company’s shareholders approved amendments to the Company’s amended and restated memorandum and articles of association
and Trust Agreement at an Extraordinary General Meeting. The amendments permit up to twelve one-month extensions of the deadline to complete an initial Business
Combination from November 2, 2026 to November 2, 2027, subject to the required approvals, implementation and extension funding. Each
one-month extension requires a $
24
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Overview
We are a blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While we intend to focus our search on businesses in the Asia Pacific and North American regions, we are not limited to a particular industry or geographic region for purposes of consummating an initial business combination. We intend to effectuate our initial business combination using cash from the proceeds of our initial public offering (“IPO”) and the private placement (“Private Placement”) of the private units (“Private Placement Units”), our shares, debt or a combination of cash, shares and debt.
On October 9, 2026, the Business Combination Agreement with Ignite was mutually terminated. Accordingly, the financing contemplated for that proposed transaction is not a source of funding for the Company’s current liquidity plans. On October 6, 2026, the Company increased the maximum principal amount available under its Sponsor note to $900,000. See Notes 5 and 10 to the unaudited condensed financial statements. The Company’s ability to continue operations depends on obtaining sufficient funding and completing an initial Business Combination within the applicable Completion Window. On November 2, 2026, the Company extended the Completion Window from November 2, 2026 to December 2, 2026. Any additional extensions under the November 2, 2026 amendment to the amended and restated memorandum and articles of association remain subject to the applicable approvals, implementation and funding requirements (see further disclosure below).
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational activities, those necessary to prepare for the IPO and those related to identifying and evaluating an initial business combination target and, following execution of the Business Combination Agreement on June 10, 2026, activities associated with pursuing the proposed Business Combination with Ignite Proteomics, LLC, including transaction execution, regulatory filings, capital raising activities and shareholder approval processes. The Ignite agreement was subsequently terminated on October 9, 2026. We do not expect to generate operating revenues until after completion of an initial business combination. We generate non-operating income in the form of interest income on the proceeds derived from the IPO, which are held in the Trust Account (defined below). After the IPO, we incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as expenses as we conduct due diligence on prospective business combination candidates.
For the three months ended September 30, 2026, net income was $615,436, comprising Trust Account income of $1,634,581 and bank interest of $300, offset by general and administrative expenses of $1,019,445. For the three months ended September 30, 2025, net income was $1,731,604, comprising Trust Account income of $1,802,094 and bank interest of $2,040, offset by general and administrative expenses of $72,530.
For the nine months ended September 30, 2026, net income was $3,389,989, comprising Trust Account income of $4,762,183 and bank interest of $1,070, offset by general and administrative expenses of $1,373,264. For the nine months ended September 30, 2025, net income was $2,570,449, comprising Trust Account income of $2,917,347 and bank interest of $3,643, offset by general and administrative expenses of $350,541.
Liquidity and Capital Resources
On May 2, 2025, we consummated our IPO of 15,000,000 units (the “Units”), at $10.00 per Unit, generating gross proceeds of $150,000,000. Simultaneously with the closing of our IPO, we consummated the sale of 499,643 Private Placement Units at a price of $10.00 per Private Placement Unit for the first 67,500 Private Placement Units purchased and at a price of $7.00 per Private Placement Unit for the remaining Private Placement Units in a private placement to our sponsor, Copley Acquisition Sponsors, LLC (the “Sponsor”), generating total gross proceeds of $3,700,001.
25
Simultaneously with the closing of the IPO, the underwriters exercised the over-allotment option in full to purchase 2,250,000 Units. As a result, we sold an additional 2,250,000 Units at $10.00 per Unit, generating gross proceeds of $22,500,000. Simultaneously with the closing of the full exercise of the over-allotment option, we completed the private sale of an aggregate of 56,250 Private Placement Units, at a purchase price of $7.00 per Private Placement Unit, generating gross proceeds of $393,750.
Transaction costs amounted to $8,257,998, consisting of $2,587,500 of cash underwriting fees, $5,175,000 of deferred underwriting fees, $322,575 for the fair value of the Representative Shares (defined below) and $172,923 of other offering costs (net of reimbursement by the underwriters).
Following the closing of the IPO and over-allotment option, an amount of $173,362,500 ($10.05 per Unit) from the net proceeds of the sale of the Units in the IPO and the Private Placement was placed in a trust account (the “Trust Account”). The funds in the Trust Account will be invested or held only in either (i) U.S. government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries, (ii) uninvested cash, or (iii) an interest-bearing bank demand deposit account or other accounts at a bank. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, to complete our initial business combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
We will use funds held outside of the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a business combination, and to pay taxes to the extent the interest earned on the Trust Account is not sufficient to pay our taxes.
On October 9, 2026, the parties mutually terminated the Ignite Business Combination Agreement. The financing contemplated under that agreement is not available as a source of funding under the terminated transaction. We remain responsible for our own transaction and termination expenses under the Termination Agreement. On October 6, 2026, the maximum principal amount available under our Sponsor note was increased from $450,000 to $900,000. See Notes 5 and 10 to the unaudited condensed financial statements.
During the nine months ended September 30, 2026, we used $400,119 of cash in operating activities and received $443,153 of proceeds under our working capital financing, resulting in a net increase in cash of $43,034. At September 30, 2026, cash outside the Trust Account was $110,602. Our liquidity requirements include payment of existing obligations, costs associated with the terminated transaction, ongoing public-company expenses and costs of pursuing another initial business combination. The Trust Account is restricted and is not available to fund ordinary operating expenses except as permitted under the governing arrangements.
On November 2, 2026, the Company’s shareholders approved amendments to the Company’s amended and restated memorandum and articles of association and Trust Agreement at an Extraordinary General Meeting. The amendments permit up to twelve one-month extensions of the deadline to complete an initial Business Combination from November 2, 2026 to November 2, 2027, subject to the required approvals, implementation and extension funding. Each one-month extension requires a $200,000 deposit into the Trust Account by the Sponsor or its affiliates or designees in exchange for a borrowing under a non-interest bearing, unsecured promissory note dated November 2, 2026 with a maximum aggregate principal amount of $2,400,000. In connection with the extension, the Company has caused $200,000 to be deposited into the Trust Account as the first drawdown under the promissory note, in order to extend the period of time the Company has to complete an initial Business Combination for an additional one-month period, from November 2, 2026 to December 2, 2026. The Sponsor and its affiliates or designees are not obligated to fund any such extensions.
In connection with the Extraordinary General Meeting held on November 2, 2026, holders of 12,899,720 Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.63 per share, for an aggregate redemption amount of approximately $137.1 million leaving approximately $46.2 million in the Trust Account and 4,350,280 Class A ordinary shares subject to possible redemption remain issued and outstanding.
26
We expect our primary liquidity requirements outside of extension funding during that period to include approximately $200,000 for legal, accounting, due diligence, travel and other expenses in connection with any business combinations; $75,000 for legal and accounting fees related to regulatory reporting requirements; $85,000 for NYSE continued listing fees; $100,000 for directors’ and officers’ insurance and $15,000 for general working capital that will be used for miscellaneous expenses and reserves, net of estimated interest income.
These amounts are estimates and may differ materially from our actual expenses. If our available funds are not sufficient, we may be unable to continue searching for, or conducting due diligence with respect to, prospective target businesses.
Moreover, if our estimates of the costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination. Moreover, we may need to obtain additional financing either to complete our initial business combination or because we become obligated to redeem a significant number of our public shares upon completion of our initial business combination, in which case we may issue additional securities or incur debt in connection with such business combination.
Going Concern Consideration
As of September 30, 2026, the Company had cash of $110,602 and a working capital deficit of $1,420,286. The Company has incurred and expects to continue to incur significant costs as a publicly traded company, to evaluate business opportunities, and to close on a Business Combination. Such costs will be incurred prior to generating any operating revenues. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 205-40, “Presentation of Financial Statements - Going Concern,” management has determined that the Company lacks the financial resources it needs to sustain operations for a reasonable period of time, which is considered to be one year from the date of the issuance of the condensed financial statements. Mandatory liquidation at the end of the Completion Window is a liquidity condition that raises substantial doubt about the Company’s ability to continue as a going concern.
In addition, the Company’s officers, directors and Sponsor may, but are not obligated to, provide additional Working Capital Loans to fund operating activities and transaction costs pending completion of the proposed Business Combination. As of September 30, 2026, the outstanding balance under the Working Capital Loan was $589,762.
On October 9, 2026, the Business Combination Agreement with Ignite was mutually terminated. Accordingly, the financing contemplated for that proposed transaction is not a source of funding for the Company’s current liquidity plans. On October 6, 2026, the Company increased the maximum principal amount available under its Sponsor note to $900,000 (see Notes 5 and 10). The Company’s ability to continue operations depends on obtaining sufficient funding and completing an initial Business Combination within the applicable Completion Window. On November 2, 2026, the Company extended the Completion Window from November 2, 2026 to December 2, 2026. Any additional extensions under the November 2, 2026 amendment to the Company’s amended and restated memorandum and articles of association remain subject to the applicable approvals, implementation and funding requirements (see further disclosure above).
If the Company is unable to obtain sufficient financing or complete an initial Business Combination within the applicable Completion Window, it may be required to curtail operations and liquidate in accordance with its amended and restated memorandum and articles of association. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date these unaudited condensed financial statements are issued. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.
27
Related Party Transactions
Founder Shares
On December 3, 2024, the Sponsor received 5,750,000 of the Company’s Class B ordinary shares (“Founder Shares”) in exchange for $25,000 paid for deferred offering costs borne by the Sponsor. Up to 750,000 of such Founder Shares were subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full. On May 2, 2025, the over-allotment option was exercised in full, resulting in no forfeiture of Founder Shares.
Private Placement
On May 2, 2025, the Company consummated the sale of 499,643 Private Placement Units at a price of $10.00 per Private Placement Unit for the first 67,500 Private Placement Units sold and at a price of $7.00 for each additional Private Placement Unit in a private placement to the Sponsor, generating gross proceeds of $3,700,001 to the Company. On May 2, 2025, with the closing of the full exercise of the over-allotment option, we completed the private sale of an aggregate of additional 56,250 Private Placement Units, at a purchase price of $7.00 per Private Placement Unit, generating gross proceeds of $393,750.
Due to Related Party
The Sponsor paid certain formation, operating or deferred offering costs on behalf of the Company. These amounts are due on demand and non-interest bearing. During the period from November 26, 2024 (inception) through May 2, 2025, the Sponsor paid $276,803 on behalf of the Company, of which $25,000 was paid in exchange for the issuance of Founder Shares and $251,803 was transferred into the Promissory Note. As of September 30, 2026 and December 31, 2025, no amounts were due to the related party.
Promissory Note - Related Party
On December 3, 2024, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $700,000. On April 18, 2025, the Promissory Note was amended and restated, resulting in a reduction of the maximum aggregate principal amount to $525,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) December 31, 2025, or (ii) the consummation of the Initial Public Offering. After borrowing under the Promissory Note, the loans were to be repaid upon completion of the Initial Public Offering out of the offering proceeds not held in the Trust Account.
On May 2, 2025, the $251,803 balance due to the Sponsor was transferred into the Promissory Note. On May 30, 2025, $105,194 of these borrowings were repaid using proceeds not held in the Trust Account, resulting in a balance of $146,609, which was transferred into a Working Capital Loan on June 12, 2025. Following the repayment and transfer, the Promissory Note was settled in full, resulting in no balance as of September 30, 2026 or December 31, 2025, and no further borrowings are permitted under its terms.
On November 2, 2026, the Company issued a non-interest bearing, unsecured promissory note with a maximum aggregate principal amount of $2,400,000 and maturity on the earlier of (i) the consummation of an initial Business Combination and (ii) the Company’s liquidation. The proceeds from borrowing under the promissory note are be used to fund up to twelve one-month extensions of the deadline to complete an initial Business Combination from November 2, 2026 to November 2, 2027, subject to the required approvals. In connection with the extension, the Company has caused $200,000 to be deposited into the Trust Account as the first drawdown under the promissory note, in order to extend the period of time the Company has to complete an initial Business Combination for an additional one-month period, from November 2, 2026 to December 2, 2026.
28
Working Capital Loans
In order to fund working capital deficiencies or finance transaction costs in connection with initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain officers and directors may, but are not obligated to, loan the Company funds as may be required, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion (“Working Capital Loans”). In addition, the Sponsor or an affiliate of the Sponsor or certain officers and directors may loan the Company funds of up to $3,450,000 (assuming the underwriters exercise their over-allotment option, and no public shares have been redeemed at the time of each extension) to cover the cost of extension options to allow additional time to complete an initial Business Combination (“Extension Loans”). The conversion terms of the Company’s executed Working Capital Loan are described below. Any additional Working Capital Loans or Extension Loans would be subject to the terms of the applicable arrangements. The units would be identical to the Private Placement Units and include one-half of one private warrant (each a “Working Capital Warrant” or “Extension Warrant”, respectively). If the Company does not complete an initial Business Combination, the Working Capital Loans and Extension Loans would be repaid out of funds not held in the Trust Account, and only to the extent available. Except for the foregoing, the terms of such Working Capital Loans and Extension Loans by the Sponsor or its affiliates, or officers and directors, if any, have not been determined and no written agreements exist with respect to such loans (except as disclosed below).
On June 12, 2025, the Company entered into a Working Capital Loan with the Sponsor, pursuant to which the Company may borrow up to $450,000. The Working Capital Loan is non-interest bearing and matures on the earlier of (i) the date on which the Business Combination is consummated and (ii) the Company’s liquidation and is subject to conversion into units (as disclosed above). On June 12, 2025, the outstanding balance of $146,609 under the Company’s Promissory Note was transferred into the Working Capital Loan. During the nine months ended September 30, 2026, the Company received additional proceeds of $443,153 under the Working Capital Loan. On October 6, 2026, the maximum aggregate principal amount available under the Working Capital Loan was increased from $450,000 to $900,000 pursuant to an amended and restated convertible promissory note (See Note 10 to the unaudited condensed financial statements), which retrospectively covered the additional borrowings. As of September 30, 2026 and December 31, 2025, the outstanding balance of the Working Capital Loan was $589,762 and $146,609, respectively. No Extension Loans were outstanding as of September 30, 2026 or December 31, 2025.
We expect to continue incurring legal, accounting, consulting, filing, regulatory and other expenses as a public company and while pursuing an initial business combination. We may require additional funding to pay existing obligations and future expenses. The increase in the Sponsor note limit does not itself constitute receipt of additional cash. Any additional funding and any extension of the Completion Window remain subject to the applicable terms, approvals and funding requirements. There can be no assurance that sufficient financing will be available on acceptable terms or that an initial business combination will be completed within the applicable deadline.
Other Contractual Obligations
Registration Rights
Pursuant to a registration rights agreement dated on the effectiveness of the Registration Statement on April 30, 2025, the holders of the Founder Shares, Private Placement Units (including securities contained therein), and units (including securities contained therein) that may be issued on conversion of working capital loans or extension loans are entitled to registration rights pursuant to a registration rights agreement, signed on the effective date of the IPO, requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company completion of initial business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
29
Underwriting Agreement
The Company granted the underwriters a 45-day option to purchase up to 2,250,000 additional Units to cover over-allotments at the IPO price, less the underwriting discounts and commissions.
The underwriters were entitled to a cash underwriting discount of $0.15 per Unit, or $2,587,500 in the aggregate, payable upon the closing of the IPO. In addition, the underwriters are entitled to a deferred fee of $0.30 per Unit, or $5,175,000 in the aggregate.
In addition, the Company issued to the representative of the underwriters an aggregate of 172,500 Class A ordinary shares for no cash consideration at the closing of the IPO (the “Representative Shares”).
On May 2, 2025, the underwriters exercised the over-allotment option in full to purchase 2,250,000 Units. As a result, the Company sold an additional 2,250,000 Units at $10.00 per Unit, generating gross proceeds to the Company of $22,500,000.
Critical Accounting Estimates
The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. As of September 30, 2026, we have not identified any critical accounting policies or estimates.
Off-Balance Sheet Arrangements; Commitments and Contractual Obligations; Quarterly Results
Our material contractual obligations and commitments are described under Related Party Transactions and Other Contractual Obligations above and in Notes 5, 6 and 10 to the unaudited condensed financial statements. We remain responsible for our own costs of the terminated Ignite transaction. Our liquidity assessment also considers the applicable completion deadline and any extension funding requirements.
JOBS Act
On April 5, 2012, the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our condensed financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.
Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things: (1) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act; (2) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act; (3) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis); and (4) disclose certain executive compensation-related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of the IPO or until we are no longer an “emerging growth company,” whichever is earlier.
Recent Accounting Standards
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.
30
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Co-Chief Executive Officers and Chief Financial Officer, to allow timely decisions regarding required disclosure.
As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Co-Chief Executive Officers and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2026. Based upon their evaluation, our Co-Chief Executive Officers and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were effective.
Management’s Report on Internal Controls Over Financial Reporting
This Quarterly Report on Form 10-Q does not include a report of management’s assessment regarding internal control over financial reporting or an attestation report of our independent registered public accounting firm due to a transition period established by rules of the SEC for newly public companies.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
31
PART II - OTHER INFORMATION
Item 1. Legal Proceedings.
None.
Item 1A. Risk Factors.
In addition to the other information set forth in this report, you should carefully consider the factors discussed in “Risk Factors” contained in our (i) Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2026, and (ii) Prospectus dated April 30, 2025. As of the date of this Report, other than as set forth below, there have been no material changes with respect to those risk factors.
The Business Combination Agreement with Ignite has been terminated, and we may not be able to identify and complete an alternative initial Business Combination within the Completion Window.
On October 9, 2026, we and the other parties to the Business Combination Agreement with Ignite mutually terminated that agreement. We have incurred substantial costs in pursuing the Ignite transaction, which we must bear ourselves under the Termination Agreement, and the financing contemplated for that transaction is no longer available to us. We must now identify a new target business, negotiate and execute a definitive agreement, and obtain the required approvals within a limited period. There can be no assurance that we will be able to do so before the expiration of the Completion Window, in which case we would be required to cease operations, redeem our Public Shares and liquidate.
Redemptions have reduced the funds available in the Trust Account.
In connection with the Extraordinary General Meeting held on November 2, 2026, holders of 12,899,720 Public Shares exercised their right to redeem their shares for cash, resulting in approximately $137.1 million being removed from the Trust Account. Following these redemptions, approximately $46.2 million remained in the Trust Account. The reduced amount in the Trust Account may make it more difficult for us to satisfy the minimum cash and other closing conditions of any initial Business Combination, and may reduce the per-share liquidation value of the Trust Account if we are unable to consummate an initial Business Combination by November 2, 2027.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
None.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
32
Item 6. Exhibits.
| Exhibit No. | Description | |
| 31.1* | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 31.2* | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 32** | Certification Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 101.INS | Inline XBRL Instance Document. | |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. | |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
| * | Filed herewith. | |
| ** | Furnished herewith. |
33
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Date: November 19, 2026 | Copley Acquisition Corp | |
| By: | /s/ Francis Chi Yin Ng | |
| Francis Chi Yin Ng | ||
| Co-Chief Executive Officer | ||
| By: | /s/ Menghan Zhang | |
| Menghan Zhang | ||
| Chief Financial Officer, President |
34